dCELL® Technology

Our unique, patented dCELL® Technology is revolutionizing the treatment of complex and unmet clinical needs 

dCELL® Technology

Our unique, patented dCELL® Technology is revolutionizing the treatment of complex and unmet clinical needs 

The Power of dCELL® Technology

dCELL Technology offers a unique approach to regenerative medicine.

The dCELL Technology process is gentle and efficient — and powerful: It produces allograft and xenograft tissue matrices that retain the native collagen structure, and an intact extracellular matrix.

The dCELL® process removes cellular and DNA material from biological tissues, through a patented series of gentle washes, leaving intact an extracellular matrix upon which the patient's cells can regenerate and repopulate, so that new tissue is created which is recognized and accepted by the body, rather than being at risk of rejection.

The dCELL® Technology difference is clear

dCELL Technology provides an enhanced healing environment, in terms of both natural, tissue-specific physical structure and biomechanical properties. Grafts made using dCELL Technology give the patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength.  Once repopulation is complete, the graft is effectively a natural part of the patient’s own tissue.  

Currently Tissue Regenix is focusing on addressing complex and unmet clinical needs in wound care, orthopedics and heart valve replacement. 

dCell technology: How it works